Clinical trials
Terminated Glioma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
132 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 10 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 8 |
| 2016 | 7 |
| 2017 | 12 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 132 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 11 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 |
| Wake Forest University Health Sciences | 6 |
| Case Comprehensive Cancer Center | 4 |
| Duke University | 4 |
| M.D. Anderson Cancer Center | 4 |
| University of California, San Francisco | 4 |
| Annick Desjardins | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Nader Sanai | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 132 |
| Glioblastoma | 67 |
| Brain Neoplasms | 52 |
| Astrocytoma | 48 |
| Oligodendroglioma | 33 |
| Gliosarcoma | 25 |
| Ependymoma | 14 |
| Central Nervous System Neoplasms | 11 |
| Neoplasms | 11 |
| Medulloblastoma | 9 |
Trials
Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.
32 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.